Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population

Clinical trial NCT05724446 · RECRUITING

Trial details

NCT number: NCT05724446
Sponsor: Salvat
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cataracts Infantile

Start date: 2022-12-12
Primary completion: 2025-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.